Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients. // Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S2405579426000616?dgcid=rss_sd_all
Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://www.sciencedirect.com/science/article/pii/S2405579426000616?dgcid=rss_sd_all
“Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
@article{article52787,
title = {Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients},
journal = {Journal of Clinical Tuberculosis and Other Mycobacterial Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S2405579426000616?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...